Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases

Details for Australian Patent Application No. 2004285343 (hide)

International Classifications

Event Publications

22 June 2006 PCT application entered the National Phase

PCT publication WO2005/041965 Priority application(s): WO2005/041965

13 May 2010 Application Accepted

Published as AU-B-2004285343

9 September 2010 Standard Patent Sealed

31 May 2012 Assignment Registered

Cytrx Corporation The patent has been assigned to Orphazyme ApS

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.